Psychedelics and virtual reality: parallels and applications.
Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch
Ther Adv Psychopharmacol August 14, 2020 DOI: 10.1177/2045125320948356 via PubMed Central
Summary
AI-generated from the abstractPsychedelic drugs and virtual reality (VR) both disrupt the rigidity of typical conscious experience. They alter sensory experience and evoke awe, and each is used alongside traditional therapies to treat mood disorders by transiently shifting perspective and disrupting rigid mental patterns. Recreational users already combine psychedelics and VR to enhance their experience. The authors propose VR could prepare hallucinogen-naïve clinical trial participants for the sensory distortions of psychedelic states and optimize the environment in psychedelic sessions. The article outlines connections between psychedelics and VR, reflecting growing scientific interest in technology, psychopharmacology, and mental health.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Altered states of consciousness Psychedelic-assisted therapy |
| Keywords | Virtual reality Vr Controlled platform Simulate |
| Citations | 50 |
| Key finding | Psychedelics and VR share capacities to alter sensory experience, evoke awe, and disrupt rigid mental patterns, and VR may serve as a tool to prepare participants for psychedelic states and optimize therapeutic settings. |
Abstract
Psychedelic drugs and virtual reality (VR) each have the capacity to disrupt the rigidity and limitations of typical conscious experience. This article delineates the parallels among psychedelic and VR states as well as their potential synergistic applications in clinical and recreational settings. Findings indicate that, individually, psychedelics and VR are used in analogous ways to alter sensory experience and evoke awe. They are also both used in tandem with traditional therapies to treat a variety of mood disorders; their shared capacity to transiently alter perspective and disrupt rigid patterns of mental experience may underly their analogous and transdiagnostic therapeutic uses. In terms of their combined applications, a number of recreational users currently utilize psychedelics and VR together to enhance their experience. We propose that VR may be a useful tool for preparing hallucinogen-naïve participants in clinical trials for the sensory distortions experienced in psychedelic states. Given the critical role of "setting" in psychedelic treatment outcomes, we also detail how VR could be used to optimize the environment in psychedelic sessions. Finally, we provide considerations for future studies and detail how advancements in psychedelic and VR research can inform one another. Collectively, this article outlines a number of connections between psychedelics and VR, and, more broadly, is representative of growing scientific interest into the interactions among technology, psychopharmacology, and mental health.